web3: BSV rose 13% this week, with the price approaching the $15 resistance level
BSV performed strongly this week, with its price briefly rising to around $14.66, marking a cumulative increase of about 13% within the week. After months of pressure, the price has broken through the previous downward trend line, showing improved short-term performance. The market's focus has shifted to the resistance zone above $15.
Price breaks downward trend line
From the current movement, BSV has climbed above its short-term moving averages, with buying activity picking up compared to earlier periods. The report notes that this round of growth is first reflected in changes to chart structure, namely the price breaking through the downward trend line that had been continuously suppressing rebounds, strengthening the short-term momentum.
Currently, the 20-day exponential moving average is around $13.71, and the 50-day exponential moving average is around $13.48. These two levels are regarded as the main support areas below the current price, providing a buffer for short-term fluctuations.
$15.30 to $15.40 becomes a key range
The most immediate resistance is concentrated in the $15.30 to $15.40 area. This zone has previously served as resistance multiple times and is the first point of observation for whether the current upward movement can continue.

- Current price is around $14.66
- 20-day moving average is around $13.71
- 50-day moving average is around $13.48
If the price can hold above $15.40, the market's focus could shift upwards to the $17.50 to $18 area. Conversely, if resistance is encountered in this zone, the price may revisit the support area of $13.70 to $13.50.
Short-term momentum remains
The report also notes that BSV's daily Relative Strength Index (RSI) is about 67, indicating strong buying momentum, but it is also approaching the overbought range, suggesting that subsequent volatility may increase.
If the price completes a retest after breaking out and holds near $15.40, the short-term structure will improve further; if it falls back below the previously broken trend line, it would signal that this breakout may be difficult to sustain.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
S&P Dow Jones Partners With Kalshi as Prediction Markets Enter Mainstream
130% Near Protocol (NEAR) Surge in Spot Inflows Secures $1.3 Million

Unable to recover 817 bitcoin, Datavault AI (DVLT.US) stock price slashed in half
Datavault AI has confirmed that it has been unable to withdraw Bitcoin from Biconomy since June, resulting in a failed asset transfer and forcing the company to restate its financial reports. As a result, its share price plummeted by 49.55% in a single day, and its book assets are expected to shrink significantly.

Regenerative medicine device company RegenLab USA (RGNA.US) sets IPO price at $6–$8 per share, aiming to raise $18 million
RegenLab USA announced its IPO terms on Tuesday.
